Search research articles
Contact Us
Filters
Showing results (91-100 of 107) with videos related to
Page
of 11
Sort By:
Journal of Cutaneous Medicine and Surgery
|
November 9, 2016
Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF)
Afsaneh Alavi, David N Adam, Ra'ed Alhusayen, et al.
Journal of Cutaneous Medicine and Surgery
|
May 22, 2016
Canadian Clinical Practice Guidelines for Rosacea
Yuka Asai, Jerry Tan, Akerke Baibergenova, et al.
Nephrologie & Therapeutique
|
February 7, 2025
French translation and adaptation of the KDIGO nomenclature for kidney function and disease
Olivier Bonny, Ibtissam Arbaoui, Denis Fouque, et al.
American Journal of Clinical Dermatology
|
June 23, 2019
Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council
Bruce Strober, Peter C M van de Kerkhof, Kristina Callis Duffin, et al.
The Journal of Investigative Dermatology
|
December 12, 2018
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis
Eric L Simpson, Shinichi Imafuku, Yves Poulin, et al.
Pediatrics
|
March 25, 2015
Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial
Bardur Sigurgeirsson, Andrzej Boznanski, Gail Todd, et al.
Journal of Cutaneous Medicine and Surgery
|
September 15, 2017
An Open Letter to Health Canada
Kim Papp, Lorne Albrecht, Kirk Barber, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
Chih-Ho Hong, Melinda J Gooderham, Lorne Albrecht, et al.
Lancet (London, England)
|
August 12, 2018
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Kenneth B Gordon, Bruce Strober, Mark Lebwohl, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
Melinda J Gooderham, Chih-Ho Hong, Lorne Albrecht, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 107) with videos related to
Sort By:
Page
of 11
Journal of Cutaneous Medicine and Surgery
|
November 9, 2016
Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF)
Afsaneh Alavi, David N Adam, Ra'ed Alhusayen, et al.
Journal of Cutaneous Medicine and Surgery
|
May 22, 2016
Canadian Clinical Practice Guidelines for Rosacea
Yuka Asai, Jerry Tan, Akerke Baibergenova, et al.
Nephrologie & Therapeutique
|
February 7, 2025
French translation and adaptation of the KDIGO nomenclature for kidney function and disease
Olivier Bonny, Ibtissam Arbaoui, Denis Fouque, et al.
American Journal of Clinical Dermatology
|
June 23, 2019
Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council
Bruce Strober, Peter C M van de Kerkhof, Kristina Callis Duffin, et al.
The Journal of Investigative Dermatology
|
December 12, 2018
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis
Eric L Simpson, Shinichi Imafuku, Yves Poulin, et al.
Pediatrics
|
March 25, 2015
Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial
Bardur Sigurgeirsson, Andrzej Boznanski, Gail Todd, et al.
Journal of Cutaneous Medicine and Surgery
|
September 15, 2017
An Open Letter to Health Canada
Kim Papp, Lorne Albrecht, Kirk Barber, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
Chih-Ho Hong, Melinda J Gooderham, Lorne Albrecht, et al.
Lancet (London, England)
|
August 12, 2018
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Kenneth B Gordon, Bruce Strober, Mark Lebwohl, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
Melinda J Gooderham, Chih-Ho Hong, Lorne Albrecht, et al.
Page
of 11